Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-27

Clinical Trial Update: Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors

View source ↗

Summary

An Imperial College London-led clinical trial is profiling microbiome-associated metabolic pathways in esophageal cancer survivors to explore links with quality…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Imperial College London | Conditions: Oesophageal Cancer, Quality of Life | Status: ACTIVE_NOT_RECRUITING